华纳药厂(688799.SH)：重酒石酸去甲肾上腺素注射液获得药品注册证书

Core Viewpoint - Warner Pharmaceuticals (688799.SH) has received approval from the National Medical Products Administration for the registration certificate of the drug "Rocuronium Bromide Injection," which is used for the treatment of acute hypotensive states and as an auxiliary treatment for cardiac arrest [1] Group 1 - The drug is indicated for restoring blood pressure in acute hypotensive states [1] - It can also be used as an auxiliary treatment for cardiac arrest and to maintain blood pressure after resuscitation [1] - The product serves as an auxiliary treatment for shock due to insufficient blood volume, helping to temporarily maintain cerebral and coronary perfusion until volume resuscitation takes effect [1]